Trials / Not Yet Recruiting
Not Yet RecruitingNCT07111416
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis (PRECISE DM Dx)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (estimated)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to learn why some adults over the age of 65, have A1c tests that do not match up with their blood glucose levels, also known as 'A1c-glucose discordance'. The main question it aims to answer is: Could alternative tests like CGM or personalized A1c provide more accurate diabetes screening in this population? Participants will be asked to perform blood tests every week to two weeks and wear a CGM for up to 8 weeks.
Conditions
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-04-01
- Completion
- 2026-05-01
- First posted
- 2025-08-08
- Last updated
- 2025-08-08
Source: ClinicalTrials.gov record NCT07111416. Inclusion in this directory is not an endorsement.